AbbVie buys Apogee for $10.9bn to acquire inflammatory disease drug
Drugmaker’s largest deal in more than half a decade comes amid surge of M&A in sector
The Source
FT
Business
AI-powered threats may succeed ‘within months’, Five Eyes warns
FT·2h ago·3 min read
Business
Britain needs more than better leadership. Here’s how we get it
FT·1h ago·3 min read
Business
America’s allies look to declare independence from the US
FT·5h ago·3 min read
Business
Hundreds of ships wait outside Gulf for full opening of Hormuz Strait
FT·6h ago·3 min read
Related
On this beat
Business
Opinion | Israel Isn’t a Party to the Iran Deal
TWSJ·53m ago·3 min read
Business
Chubb CEO flags threat disrupting global oil supply
THE STREET·1h ago·3 min read
Business
‘Ghost Jobs’ Are Becoming More Common. Now a Senator Is Demanding an Investigation Into the Practice
INC·1h ago·3 min read
Business
Alan Greenspan’s legacy explained: how the Fed became central to modern markets under America’s most influential central banker
TWSJ·34m ago·3 min read